Clinical Trial Update: A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FAPI-PET/CT imaging to predict pathological complete response after neoadjuvant chemoradiotherapy in patients with MSS rectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED